Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT05035693

Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C

Led by NGMedical GmbH · Updated on 2024-11-15

170

Participants Needed

7

Research Sites

313 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Study design: International, prospective, multicentre, non-randomised, observational study according to § 23b MPG. Objectives: Observational study to confirm the safety and performance of the cervical disc prosthesis MOVE®-C.

CONDITIONS

Official Title

Post Market Clinical Follow up Study With the Cervical Disc Prothesis MOVE®-C

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of discopathy or herniated disc with radiculopathy or stenosis of the foramen and spinal canal
  • History of neck and/or upper extremity pain or functional/neurological deficit related to the cervical level to be treated
  • No cervical spine surgery within the last six weeks before implantation
  • Unsuccessful conservative medical care within the last six weeks
  • At least 18 years of age
  • Patient agrees to fully participate and provides written informed consent
  • Patient is capable of understanding the nature, aims, and possible consequences of the trial
  • Patient information has been provided and all consent forms are completed
Not Eligible

You will not qualify if you...

  • Bone mineral density T-score .5 or lower for men aged 60 or older and women aged 50 or older as measured by spine DXA
  • Active systemic infection or infection at the surgical site
  • Sustained osteoporotic fracture of spine, hip, or wrist
  • Presence of spinal metastases
  • Known allergy to titanium or polycarbonate-urethane
  • Confirmed pregnancy
  • Severe cervical myelopathy
  • Need for treatments that destabilize the spine (e.g., posterior element decompression)
  • Advanced cervical anatomical deformity at surgery site (e.g., ankylosing spondylitis, scoliosis)
  • Advanced degenerative changes at the vertebral level to be treated (e.g., spondylosis)
  • Patient under judicial or official institutional orders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Wiener Gesundheitsverbund-Klinik Penzing

Vienna, Austria, 1180

Actively Recruiting

2

DRK Klinikum Berlin

Berlin, Germany, 14050

Actively Recruiting

3

Wirbelsäulenzentrum Fulda Main, Kinzig

Gelnhausen, Germany, 63571

Actively Recruiting

4

Medizinisches Versorgungszentrum Steinburg

Itzehoe, Germany, 25524

Actively Recruiting

5

Katholisches Klinikum Koblenz - Montabaur

Koblenz, Germany, 56073

Actively Recruiting

6

Neurochirurgie am Gasteig

München, Germany, 81669

Actively Recruiting

7

Rhein-Maas Klinikum Würselen

Würselen, Germany, 52146

Actively Recruiting

Loading map...

Research Team

S

Saskia Mathieu, M.Sc.

CONTACT

N

Nino Weiland, B.Sc.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here